Express Pharma

Glenmark, Bausch Health partner to commercialise RYALTRIS nasal spray in Canada 

RYALTRIS is currently under review by Health Canada with a proposed indication for the treatment of seasonal allergic rhinitis in adults and children over 12 years of age